Introduction
============

Metastasis to the tongue seldom occurs, and lingual metastasis as an initial sign of cancer occurs even less frequently.

Metastasis to the head and neck area from a primary site in the abdomen is rare. Renal cell carcinoma (RCC) is the third most common tumour after lung and breast to metastasize to the head and neck region. Less than 15% of patients with renal cell carcinoma actually show metastasis to this area. We discuss a case of renal cell carcinoma presenting with pathologically proven metastasis in the tongue.

Case presentation
=================

A 78-year-old man who was a chronic smoker presented to the maxillofacial department at a district general hospital with a 6-week history of difficulty in swallowing solids together with pain in his pharynx.

On examination, he was noted to have a 3 × 2 cm solitary pedunculated lesion on the right side of the anterior two-thirds of his tongue crossing the midline. His tongue mobility was normal and there was no palpable cervical lymphadenopathy.

Systematic examination of chest, abdomen and heart were normal. The lesion was biopsied and initially reported as a primary squamous cell carcinoma with some clear cell changes. His blood tests including renal functions were normal. His case was discussed in the head and neck cancer multidisciplinary team (MDT) meeting and subtotal glossectomy was planned after a staging MRI (magnetic resonant imaging) scan followed by adjuvant radiotherapy to the head and neck region. While awaiting an MRI, he presented to the hospital with severe pain in his oral cavity and difficulty in swallowing. His tongue lesion had doubled in size in a matter of two weeks and was now protruding outside the mouth (Figure [1](#F1){ref-type="fig"}). It was considered unusual for primary squamous cell carcinoma of tongue to behave like that. The pathology was therefore reviewed at the same MDT meeting and this time the lesion was reported as partly squamous epithelium covered by fibromuscular tissue showing infiltration by a carcinoma, seen in the nests with extensive clear cell changes. The differential diagnosis was considered to be squamous cell carcinoma with clear cell changes, metastatic salivary gland neoplasm or metastases from RCC. It was decided to arrange an urgent CT scan and to debulk the tongue lesion surgically, to improve his symptoms. The patient had not described any suspicious urinary symptoms.

![Tongue metastasis.](1752-1947-2-249-1){#F1}

A CT scan of the neck, chest and abdomen revealed a 4.7-cm sized irregular mass in the left kidney suggestive of RCC (Figure [2](#F2){ref-type="fig"}). There was no local extension and the left renal vein was clear. A solitary tongue lesion with no neck nodes was reported. No metastases were seen in the lungs, liver, adrenals, spleen and bones.

![CT scan showing primary tumour of left kidney.](1752-1947-2-249-2){#F2}

As per the MDT decision, he underwent a debulking surgery of the tongue metastasis, which was performed without complication. His swallowing improved significantly. Postoperatively, he received radiotherapy to his oral cavity delivering a dose of 60 Grays in 30 daily fractions over 6 weeks, which was well tolerated. Radiotherapy was given to treat the microscopic disease in his head and neck region.

A post-radiotherapy CT scan, 18 weeks after initial presentation, was arranged before radical nephrectomy, which unfortunately revealed early evidence of lung metastases. As the patient reported shoulder pain, a plain X-ray and bone scan were carried out and this revealed evidence of a solitary bone metastasis in the right scapula.

Following his debulking surgery and adjuvant radiotherapy, he underwent a radical left-sided nephrectomy. Histopathology confirmed a Fuhrman grade 3 clear cell carcinoma of the left kidney with extension into the superior perirenal fat but not into the renal sinus and with no microvascular infiltration. The maximal dimension of the tumour was 5 cm. The patient has subsequently been treated with interferon-alpha (dose: 3 MU, three times a week) as a systemic treatment for his metastatic disease. A repeat CT scan after six months of treatment showed a complete response with no evidence of any distant metastases.

Discussion
==========

RCC may remain clinically occult for most of its course. The classic presentation of pain, haematuria, and flank mass occurs in a minority of patients and is often indicative of advanced disease. A tumour in the kidney can progress unnoticed to a large size in the retroperitoneum until metastatic disease appears. It can metastasize to any location in the body, and its propensity to metastasize to unusual sites has been well documented. Approximately 30% of patients with renal carcinoma present with metastatic disease, 25% with locally advanced renal carcinoma, and 45% with localized disease \[[@B1]\]. About 75% of patients with metastatic renal carcinoma have metastases to the lung, 36% to soft tissues, 20% to bone, 18% to liver, 8% to cutaneous sites and 8% to the central nervous system \[[@B2]\]. Approximately 15% of renal cell carcinomas metastasize to the head and neck region -- specifically, to the paranasal sinuses, larynx, jaws, temporal bones, thyroid gland, and parotid glands \[[@B3],[@B4]\]. Tongue metastasis is rare.

After an exhaustive literature search, we found 28 cases which had been reported since 1911 (Table [1](#T1){ref-type="table"}). Tongue metastasis as an initial presentation of RCC is extremely rare and we found only three cases published in the literature so far, reported in 1987, 1994 and 1996 (Table [2](#T2){ref-type="table"}).

###### 

Previous case reports of renal cell carcinoma metastasizing to tongue

  S No   Author.             Year   Age/sex   Site                     Other metastases
  ------ ------------------- ------ --------- ------------------------ --------------------------------
  1      Kostenko            1911   43/M                               
  2      Coenen              1914   62/F                               
  3      McNattin & Dean     1931   58/M                               Lung, heart, skin
  4      Trinca & Willis     1936   57/M                               
  5      Schrag              1945   34/M                               Lung
  6      Del Carmen          1970   77/M                               None
  7      Satomi *et al.*     1974   41/F      Left surface             Lung
  8      Friedlander         1979   84/M      Tip of tongue            Lung
  9      Fitzgerald          1982   63/M      Right dorsum             Brain
  10     Kitao *et al.*      1986   37/M      BOT                      None
  11     Inai                1987   42/M      Left base                Lung
  12     Matsumota & Lio     1987   77/F      Left surface             Lung
  13     Kapoor              1987   70/M      Not mentioned            Not mentioned
  14     Madsion & Fereson   1988   63/M      Right ventral surface    Lung, liver
  15     Ishikawa            1991   59/F                               Lung, bone
  16     Okabe *et al.*      1992   58/M      Left base                Lung, brain
  15     Shibyama            1993   41/M      BOT                      Lung, bone, lymph nodes
  16     Ziyada              1994   59/M      Right base               None
  17     Aguirre             1996   82/F      Tip of tongue            Brain
  18     Airoldi             1995   51/M                               Lung
  19     Konya               1997   59/M                               Para-aortic, lymph nodes
  20     Tomita              1998   50/M      Left border              Lung, brain, skin
  21     Goel                1999   62/M      Left surface             Lung
  22     Navarro *et al.*    2000   62/M      Right lateral            Lung
  23     Fukuda              2002   74/M      Left side                
  24     Mariomi *et al.*    2002   87/F      Dorsum                   Lung, liver, thyroid, pancreas
  25     Emer *et al.*       2003   45/M      Tip of tongue            Nose, lungs
  26     Kyan & Kato         2004   66/M      Base of tongue           Lungs
  27     Torres-Carranza     2006   49/F      Middle third of dorsum   Lungs
  28     Huang & Chang       2006   76/F      BOT                      Lungs, liver
  29     Present case        2007   68/M      Anterior right lateral   Lungs, bone

BOT, base of tongue.

###### 

Tongue metastasis as the initial presentation of renal cell carcinoma

  S No   Authors                           Year   Age/sex   Site                     Other metastases
  ------ --------------------------------- ------ --------- ------------------------ ------------------
  1      Kapoor *et al.*\[[@B10]\]         1987   70/M      Not mentioned            Not mentioned
  2      Ziyada *et al.*\[[@B11]\]         1994   59/M      Right BOT                None
  3      Aguirre and Rinaggio \[[@B12]\]   1996   82/F      Tip of tongue            Brain
  5      Present case                      2007   68/M      Anterior right lateral   Lungs, bone

BOT, base of tongue.

Possible routes of metastatic spread to the tongue are the arterial, venous and lymphatic circulation. Metastases are mostly located on the base of the tongue possibly due to its rich vascular supply, through the dorsal lingual artery, and due to immobility as compared to other parts of the tongue. RCC invades the local vascular network of the kidney and spreads through the systemic circulation. Head and neck metastasis is commonly associated with lung metastases. If there are no signs of pulmonary disease, as in our case initially, it is possible that spread has been via Batson\'s venous plexus or via the thoracic duct. Batson\'s venous plexus extends from the skull to the sacrum. This valveless system theoretically offers less resistance to the spread of tumour emboli, especially when there is an increase in intrathoracic and intra-abdominal pressure, allowing retrograde flow by-passing pulmonary filters \[[@B5]\].

Nephrectomy may be justified in patients with metastatic disease to improve quality of life or local symptoms and to confer a possible survival advantage \[[@B6]\]. However, it is not justified when the intention is to induce spontaneous tumour regression which occurs in less than 1% of cases.

Management of tongue metastasis is surgical excision and this was followed in our patient by adjuvant radiotherapy to achieve local control of disease. Chemotherapeutic agents including fluoropyrimidines together with biological agents such as interferon-α can offer a palliative benefit in some patients with RCC. Shibayama *et al.*reported a complete response in a base of the tongue metastasis after interferon-α therapy \[[@B7]\]. Newer agents such as sorafenib and sunitinib have been shown to improve progression-free survival in metastatic RCC \[[@B8],[@B9]\]. Temsirolimus and bevacizumab have also shown promise in early phase trials.

A thorough evaluation to distinguish between primary and secondary tongue cancer is essential. Primary cancer of the tongue is treated with curative intent and this includes total glossectomy with or without neck node dissection followed by radical radiotherapy in the early stages and concomitant chemotherapy (cisplatinum and 5 fluorouracil) and radiotherapy in the later stages.

Secondary tumours of the tongue are managed with palliative intent, which includes surgery, radiotherapy and immunotherapy. The prognosis of metastatic RCC is poor and 5-year survival is less than 10%.

Conclusion
==========

Twenty-eight case reports of tongue metastasis from kidney cancer since 1911 have been documented (Table [1](#T1){ref-type="table"}) and its occurrence as a presentation of kidney cancer was found to be extremely rare with only three cases reported in the last century (Table [2](#T2){ref-type="table"}) before the current case.

Metastatic spread to the tongue may occur in advanced stages of RCC. The prognosis of patients with tongue metastasis is poor because most of them have widespread disease. Similar to primary tumours of the tongue, metastatic lesions may be ulcerated or polypoid. Clinical and even histological differentiation between the two conditions can be challenging. Since the tongue is a rare metastatic site, when a lesion is detected, a thorough evaluation should be made to distinguish between metastasis and primary cancer, so that appropriate treatment can be offered.
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